A significant discovery in cancer research is arising with the use of mini-antibodies to re-engage mutated p53. This crucial malignant inhibitor protein is frequently inactivated in several kinds of cancer, resulting https://socialrator.com/story13359513/nanobodies-reactivate-the-p53-protein-the-potential-pathway-for-malignant-management